ribonuclease-targeting chimeras
Construct PatternBetween 2020 and 2025, major progress has been achieved across five modalities: ... and ribonuclease-targeting chimeras (RIBOTACs). Each exploits endogenous degradation or regulatory pathways using chemically engineered bifunctional or monofunctional small molecules, thereby expanding the druggable proteome and transcriptome.